Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 1, 1996, Pages 261-267

  Korte, S Mechiel ^a   Korte Bouws, Gerdien A H ^a   Koob, George F ^b   De Kloet, E Ronald ^c   Bohus, Béla ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c NONE

Author keywords

anxiety; defensive burying; fear; fear potentiated startle; glucocorticoid receptor; mineralocorticoid receptor

Indexed keywords

GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; MIFEPRISTONE; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; OXPRENOATE POTASSIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; BEHAVIOR; CONFERENCE PAPER; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; FEAR; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STARTLE REFLEX;

EID: 0029868791     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02172-8     Document Type: Conference Paper

References (47)

1. Bohus, B. Humoral modulation of learning and memory processes: Physiological significance of brain and peripheral mechanisms. In: Delacour, J., ed. The memory system of the brain. London: World Scientific Publishing Co.; 1994:337-364.
2. Brown, J.; Kalish, H.; Farber, I. Conditioned fear as revealed by magnitude of startle response to an auditory stimulus. J. Exp. Psychol. 41:317-327; 1951.
3. Chao, H. M.; Choo, P. H.; McEwen, B. S. Glucocorticoid and mineralocorticoid receptor mRNA expression in rat brain. Neuroendocrinology 50:365-371; 1989.
4. Davis, M. The role of the Amygdala in conditioned fear. In: Aggleton, J. P., ed. The amygdala: Neurobiological aspects of emotion, memory and mental dysfunction. New York: Wiley-Liss Inc.; 1992:255-305.
5. De Boer, S. F.; Van der Gugten, J. Daily variations in plasma noradrenaline, adrenaline and corticosterone concentrations in rats. Physiol. Behav. 40:323-328; 1987.
6. De Boer, S. F.; Slangen, J. L.; Van der Gugten, J. Plasma catecholamine and corticosterone levels during active and passive shock-prod avoidance behavior in rats: Effects of chlordiazepoxide. Physiol. Behav. 47:1089-1098; 1990.
7. De Kloet, E. R.; De Kock, S.; Schild, V.; Veldhuis, H. D. Antiglucocorticoid RU38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites. Neuroendocrinology 47:109-115; 1988.
8. De Kloet, E. R. Brain corticosteroid receptor balance and homeostatic control. Front. Neuroendocrinol. 12:95-164; 1991.
9. Diamant, M.; Croiset, G.; De Wied, D. The effect of corticotropin-releasing factor (CRF) on autonomie and behavioral responses during shock-prod burying test in rats. Peptides 13:1149-1158; 1992.
10. Fernandez-Guasti, A.; Picazo, O. The actions of diazepam and serotonergic anxiolytics vary according to the gender and the estrous cycle phase. Pharmacol. Biochem. Behav. 37:77-81; 1990.
11. File, S. E.; Vellucci, S. V.; Wendlandt, S. Corticosterone - An anxiogenic or an anxiolytic agent? J. Pharm. Pharmacol. 31:300-305; 1979.
12. Fuxe, K.; Wikström, A. C.; Okret, S.; Agnati, L. F.; Härfstrand, A.; Yu, Z. Y.; Granholm, L.; Zoli, M., Vale, W.; Gustafsson, J. A. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 117: 1803-1812; 1985.
13. Gaillard, R. C.; Riondel, A.; Muller, A. F.; Herrmann, W.; Bauileu, E. E. RU486: A steroid with antiglucocorticoid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc. Natl. Acad. Sci. USA 81:3879-3882; 1984.
14. Grillon, C.; Ameli, R.; Woods, S. W.; Merikangas, K.; Davis, M. Fear-potentiated startle in humans: Effects of anticipatory anxiety on the acoustic blink reflex. Psychophysiology 28:588-595; 1991.
15. Heinrichs, S. C.; Pich, E. M.; Miczek, K. A.; Britton, K. T.; Koob, G. F. Corticotropin-releasing factor anatagonist reduces emotionality in socially fefeated rats via direct neurotrophic action. Brain Res. 581:190-197; 1982.
16. Herman, J. P.; Patel, P. D.; Akil, H.; Watson, S. J. Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol. Endocrinol. 3:1886-1894; 1989.
17. Hijzen, T. H.; Slangen, J. L. Effects of midazolam, DMCM and lindane on potentiated startle in the rat. Psychopharmacology (Berlin) 99:362-365; 1989.
18. Jefferys, D.; Funder, J. W. Glucocorticoids, adrenal medullary opioids, and the retention of a behavioral response after stress. Endocrinology 12:1006-1009; 1987.
19. Johnston, A. L.; File, S. E. Sex differences in animal tests of anxiety. Physiol. Behav. 49:245-250; 1991.
20. Korte, S. M.; Bonus, B. The effect of ipsapirone on the behavioural and cardiac responses in the shock-probe/defensive burying test in male rats. Eur. J. Pharmacol. 187:307-310; 1990.
21. Korte, S. M. Stress and anxiety: A behavioural pharmacological study of neuroendocrine and autonomic correlates in rats. Thesis University of Groningen, The Netherlands; 1991.
22. Korte, S. M.; De Boer, S. F.; De Kloet, E. R.; Bohus, B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 20(4):385-394; 1995.
23. Korte, S. M.; Bouws, G. A. H.; Koolhaas, J. M.; Bohus, B. Neuroendocrine and behavioral responses during conditioned active and passive behavior in the defensive burying/probe avoidance paradigm: Effects of ipsapirone. Physiol. Behav. 52:355-361; 1992.
24. Leaton, R. N.; Borszcz, G. S. Potentiated startle: Its relation to freezing and shock intensity in rats. J. Exp. Psychol. Animal. Behav. Process. 11(3):421-428; 1985.
25. LeDoux, J. E.; Iwata, J.; Cicchetti, P.; Reis, D. J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 8(7): 2517-2529; 1988.
26. LeDoux, J. E. Emotional memory systems in the brain. Behav. Brain Res. 58(1-3):69-79; 1993.
27. McEwen, B. S.; Weiss, J.; Schwartz, L. Selective retention of corticosterone by limbic structures in rat brain. Nature 220:911-912; 1968.
28. Meaney, M. J.; Mitchell, J. B.; Aitken, D. H.; Bhatnagar, S.; Bodnoff, S. R.; Iny, L. J.; Sarrieau, A. The effects of neonatal handling on the development of the adrenocortical response to stress: Implications for neuropathology and cognitive deficits in later life. Psychoneuroendocrinology 16:65-103; 1991.
29. Moguilewski, M.; Philibert, D. RU38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impairment activation. J. Steroid. Biochem. 20:271-276; 1984.
30. Oitzl, M. S.; De Kloet, E. R. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav. Neurosci. 106:62-71; 1992.
31. Oitzl, M.S.; Josephy, M.;Spruijt, B. M. An ACTH/MSH(4-9)analog counteracts the behavioral effects of a mineralocorticoid receptor antagonist. Pharmacol. Biochem. Behav. 44:447-450; 1993.
32. Oitzl, M. S.; Fluttert, M.; De Kloet, E. R. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticoid receptors. Eur. J. Neurosci. 6:1072-1079; 1994.
33. Papolos, D. F.; Edwars, E.; Marmur, R.; Lachman, H. M.; Henn, F. Effects of the antiglucocorticoid RU38486 on the induction of learned helpless behavior in Spraque-Dawley rats. Brain Res. 615:304-309; 1993.
34. Pellegrino, L. J.; Cushman, A. J. A stereotaxic atlas of the rat brain. New York: Appleton-Century-Crofts; 1976.
35. Peeters, B. W. M. M.; Smets, R. J. M.; Broekkamp, C. L. E. The involvement of glucocorticoids in the acquired immobility response is dependent on the water temperature. Physiol. Behav. 51:127-129; 1992.
36. Perroteau, I.; Netchitailo, P.; Delarue, C.; Leboulenger, F.; Philibert, D.; Deraedt, R.; Vaudry, H. The effect of the antimineralocorticoid RU28318 on aldosterone biosynthesis in vitro. J. Steroid. Biochem. 20:853-856; 1984.
37. Pesold, C.; Treit, D. The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 638: 295-301; 1994.
38. Pinel, J. P.; Treit, D. The conditioned defensive burying paradigm and behavioral neuroscience. In: Robinson, T., ed. Behavioral approaches to brain research. New York: Oxford University Press; 1983:212-234.
39. Piazza, P. V.; Maccari, S.; Deminiere, J. M.; Le Moal, M.; Mormede, P.; Simon, H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. USA 88:2088-2092; 1991.
40. Piazza, P. V.; Deroche, V.; Deminiere, J. M.; Maccari, S.; Le Moal, M.; Simon, H. Corticosterone in the range of stress-induced levels possesses reinforcing properties: Implications for sensation-seeking behaviors. Proc. Natl. Acad. Sci. USA 90: 11738-11742; 1993.
41. Reul, J. M. H. M.; De Kloet, E. R. Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 117:117-123, 1985.
42. Reul, J. M. H. M.; Van Den Bosch, F. R.; De Kloet, E. R. Differential response of type 1 and type 2 corticosteroid receptors to changes in plasma steroid level and circadian rhythmicity. Neuroendocrinology 45:407-412; 1987.
43. Roozendaal, B.; Koolhaas, J. M.; Bohus, B. Central amygdala lesions affect behavioral and autonomie balance during stress in rats. Physiol. Behav. 50:777-781; 1991.
44. Treit, D.; Fundytus, M. A comparison of buspirone and chlordiazepoxide in the shock-probe/burying test for anxiolytics. Pharmacol. Biochem. Behav. 30:1071-1075; 1988.
45. Treit, D.; Pesold, C.; Rotzinger, S. Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety. Behav. Neurosci. 107(5): 770-785; 1993.
46. Treit, D.; Robinson, A.; Rotzinger, S.; Pesold, C. Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test. Behav. Brain Res. 54:23-34; 1993.
47. Van Eekelen, J. A. M.; Jiang, W.; De Kloet, E. R.; Bohn, M. C. Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J. Neurosci. Res. 21: 88-94; 1988.